Penningtons Manches Cooper LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Penningtons Manches Cooper LLP has a track record in cross-border transactions with a particular focus on M&A deals with US buyers and a strong presence in the life sciences and technology sectors. The team is equipped to handle the full spectrum of corporate work, ranging from advising start-ups on funding rounds to supporting clients with business sales and IPOs. The department is chaired by London-based Matthew Martin, who also acts as the firm’s Global Head of Corporate. Important team members in Oxford include Will Axtell, whose specialisms extend to advising entrepreneurs exiting to private equity, and James Went, one of the firm’s key contacts for high-volume corporate transactions, including spin-outs and venture capital financing. Both are well-supported by Dominique Sabatini.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Through a series of prominent transactions, the team has extensive (and probably unrivalled) experience in Health Economics. They are practical, thorough, and their advice is excellent.'
- ‘Will Axtell is the standout individual. It is often hard to get advice or a view from a lawyer, whereas Will is willing to interpret and give you the balance of probabilities on which to make your choice.'
Key clients
- Cibus Fund
- Elis UK
Work highlights
Advised the shareholders of Delta Hat on its acquisition by Petauri, a UK-USA cross-border transaction in the life sciences/healthcare sector.